NCT07594717 Effects of E-Cigarette Flavors on Adult E-Cigarette Users With Opioid Use Disorder
| NCT ID | NCT07594717 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Prisma Health-Upstate |
| Condition | Nicotine Use Disoder |
| Study Type | OBSERVATIONAL |
| Enrollment | 70 participants |
| Start Date | 2025-11-12 |
| Primary Completion | 2026-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 70 participants in total. It began in 2025-11-12 with a primary completion date of 2026-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study examines the effects of e-cigarette (EC) flavors among adults with opioid use disorder (OUD) receiving buprenorphine treatment who currently use e-cigarettes. Participants will smell and rate 11 EC flavors based on appeal, sensory characteristics, and likelihood of future use. Researchers will examine how different flavor profiles influence the appeal and reinforcing effects of ECs in this population. The goal is to identify EC flavors that may enhance the acceptability of ECs as a potential harm-reduction strategy among adults with OUD receiving buprenorphine treatment.
Eligibility Criteria
Inclusion Criteria: * Adults aged 21 years or older. * Current e-cigarette users who report e-cigarette use on ≥20 of the past 30 days. * Former daily cigarette smokers who currently smoke on ≤19 days per month and no more than 5 cigarettes per day. * Diagnosed with opioid use disorder (OUD). * Currently receiving buprenorphine treatment for OUD. Exclusion Criteria: \-
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07594717 clinical trial?
This trial is open to participants of all sexes, aged 21 Years or older, studying Nicotine Use Disoder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07594717 currently recruiting?
Yes, NCT07594717 is actively recruiting participants. Contact the research team at iperico@clemson.edu for enrollment information.
Where is the NCT07594717 trial being conducted?
This trial is being conducted at Greenville, United States.
Who is sponsoring the NCT07594717 clinical trial?
NCT07594717 is sponsored by Prisma Health-Upstate. The trial plans to enroll 70 participants.